Back to Market Feed

Product Information

ONYDA XR 0.1 MG/ML SUSPENSION is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $13.3769 per ML under NDC 24478014803. Its NADAC has been published 83 times since Jan 22, 2025.

FDA first approved this application on May 24, 2024.

The High Outlier badge above means this manufacturer's average price in the Clonidine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ONYDA XR 0.1 MG/ML SUSPENSION

Clonidine hydrochloride
$13.3769per ML
High Outlier

Strength

.1 mg/mL

NDC

24478014803

Classification

Brand

Dosage Form

SUSPENSION, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CLONIDINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA217645

FDA Approved

5/24/2024

On Market Since

8/13/2024

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for ONYDA XR 0.1 MG/ML SUSPENSION has been published 83 times since Jan 22, 2025, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.

Current price$13.3769 per ML
All-time high$15.3592 (Mar 5, 2025)
All-time low$12.8369 (Nov 19, 2025)
52-week high$13.3992
52-week low$12.8369
Median price$13.3767
Average price$13.3050
Largest weekly change-16.0% (Mar 12, 2025)
Weeks tracked83
Tracking sinceJan 22, 2025

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.2%

1Y

+4.1%

3Y

N/A

5Y

N/A

All

-12.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clonidine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

INTUNIV ER 4 MG TABLET
Brand
54092051902•Takeda Pharmaceuticals America, Inc.
$9.2912
per EA
INTUNIV ER 3 MG TABLET
Brand
54092051702•Takeda Pharmaceuticals America, Inc.
$9.2943
per EA
INTUNIV ER 2 MG TABLET
Brand
54092051502•Takeda Pharmaceuticals America, Inc.
$9.3127
per EA
INTUNIV ER 1 MG TABLET
Brand
54092051302•Takeda Pharmaceuticals America, Inc.
$9.3973
per EA

Frequently asked questions

What is the NADAC price of ONYDA XR 0.1 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for ONYDA XR 0.1 MG/ML SUSPENSION, manufactured by NextWave Pharmaceuticals, Inc, is $13.3769 per ML (NDC 24478014803), effective Aug 19, 2026.

How has the price of ONYDA XR 0.1 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for ONYDA XR 0.1 MG/ML SUSPENSION has declined 12.9%. It has been tracked across 83 weekly CMS publications since Jan 22, 2025.

What are the highest and lowest recorded NADAC prices for ONYDA XR 0.1 MG/ML SUSPENSION?

Since Jan 22, 2025, the NADAC for ONYDA XR 0.1 MG/ML SUSPENSION has ranged from a low of $12.8369 (Nov 19, 2025) to a high of $15.3592 (Mar 5, 2025), with a median of $13.3767 per ML.

Are there cheaper alternatives to ONYDA XR 0.1 MG/ML SUSPENSION?

No other NADAC-published product currently shares the active ingredient and strength of ONYDA XR 0.1 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ONYDA XR 0.1 MG/ML SUSPENSION?

ONYDA XR 0.1 MG/ML SUSPENSION (NDC 24478014803) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.